title: [Mirogabalin: The next pregabalin?]
authors: Centro de Salud José María Álvarez, Don Benito, Badajoz, España; Grupo de Trabajo de Dolor de SEMERGEN, España. Electronic address: a.alcantara.montero@hotmail.com.
authors: A
authors: A
authors: Alcántara Montero
authors: Grupo de Trabajo de Dolor de SEMERGEN, España; Centro de Salud Guillem de Castro, Valencia, España.
authors: P J
authors: PJ
authors: Ibor Vidal
mesh_terms: D000588:Amines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000700:Analgesics / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001643:Bridged Bicyclo Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000077206:Gabapentin; D006801:Humans; D000069583:Pregabalin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000588:Amines; D000700:Analgesics; D001643:Bridged Bicyclo Compounds; D003509:Cyclohexanecarboxylic Acids; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; C000598618:mirogabalin